GE HealthCare and Mayo Clinic have launched a joint initiative named GEMINI‑RT aimed at transforming the landscape of radiation therapy and cancer care. The program is planned as a long‑term research collaboration that builds on their 2023 Strategic Radiology Research Collaboration, extending that alliance into the core domain of radiation oncology.
GEMINI‑RT seeks to integrate the technological engineering capabilities of GE HealthCare with the clinical and research expertise of Mayo Clinic to deliver more personalized, data‑driven care for cancer patients. The collaboration envisions using advanced imaging, dosimetry, artificial intelligence, and continuous patient monitoring throughout the full care continuum — from diagnosis and treatment planning to therapy delivery and follow-up.
The initiative is built around four strategic areas. The first area, automation, aims to employ AI-powered tools to reduce repetitive tasks and accelerate treatment planning workflows. The second area, predictive oncology, will draw on clinical data and outcomes to tailor treatment decisions to individual patients.
The third area, multi‑modal therapies, explores combining radiation therapy with emerging treatment modalities like targeted drugs and precision heating to improve effectiveness. The fourth area, connected care, proposes the use of sensors, biomarkers, and digital monitoring to track patient status beyond the clinic — enabling early detection of side effects and better outpatient management.
The goal of GEMINI‑RT is to make personalized radiation therapy more accessible globally. Given that radiation therapy is used in more than half of all cancer cases worldwide and remains a cornerstone of cancer treatment, the collaboration comes at a time of rising global cancer incidence. Through GEMINI‑RT, the partners seek to streamline and standardize radiation oncology workflows, improve clinical outcomes, and support long-term innovation in cancer care.
Research and development under GEMINI‑RT will be based primarily at Mayo Clinic’s campus in Rochester, Minnesota. The combination of Mayo Clinic’s clinical infrastructure and real‑world outcomes data with GE HealthCare’s engineering and product development resources is expected to accelerate the translation of research findings into clinical use, with the potential to reshape how radiation therapy is delivered worldwide.
With this initiative, GE HealthCare and Mayo Clinic aim to usher in a new era of cancer care where radiation therapy is not only more precise and personalized but also more responsive to patient needs, more efficient for clinicians, and more scalable for global healthcare systems. Over time GEMINI‑RT may help expand access to advanced oncology care and redefine standard treatment protocols.
